Doxorubicin and cyclophosphamide followed by weekly docetaxel as neoadjuvant treatment of early breast cancer: analysis of biological markers in a GEICAM phase II study

被引：0
|
作者：
Laura G. Estevez
José Luis Fortes
Encarna Adrover
Gloria Peiró
Mireia Margelí
Eva Castellá
José Miguel Cuevas
Laia Bernet
Miguel Angel Segui
Xavier Andreu
机构：
[1] Fundación Jiménez Díaz,
[2] Hospital General Universitario de Alicante,undefined
[3] Hospital Universitario Germans Trias i Pujol,undefined
[4] Hospital de la Ribera,undefined
[5] Consorci Hospitalari Parc Tauli,undefined
[6] GEICAM Cooperative,undefined
来源：
Clinical and Translational Oncology | 2009年 / 11卷
关键词：
Anthracycline; Breast carcinoma; Primary chemotherapy; Sequential; Taxane; Weekly;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：54 / 59
页数：5
相关论文
共 50 条
  • [1] Doxorubicin and cyclophosphamide followed by weekly docetaxel as neoadjuvant treatment of early breast cancer: analysis of biological markers in a GEICAM phase II study
    Estevez, Laura G.
    Fortes, Jose Luis
    Adrover, Encarna
    Peiro, Gloria
    Margeli, Mireia
    Castella, Eva
    Cuevas, Jose Miguel
    Bernet, Laia
    Segui, Miguel Angel
    Andreu, Xavier
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (01): : 54 - 59
  • [2] A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer
    Schneeweiss, A.
    Marme, F.
    Ruiz, A.
    Manikhas, A. G.
    Bottini, A.
    Wolf, M.
    Sinn, H. -P.
    Mansouri, K.
    Kennedy, L.
    Bauknecht, T.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (03) : 609 - 617
  • [3] Doxorubicin/pemetrexed followed by docetaxel versus doxorubicin/cyclophosphamide followed by docetaxel as neoadjuvant treatment for early-stage breast cancer:: A randomized phase II trial
    Schneeweiss, Andreas
    Lauschner, Ilka
    Ruiz, Amparo
    Guerrero, Angel
    Sanchez-Rovira, Pedro
    Segui, Miguel Angel
    Goerke, Kay
    Wolf, Michael
    Manikhas, Alexey G.
    Wacker, Juergen
    Marme, Frederik
    Lichter, Peter
    Sinn, Hans-Peter
    Sohn, Christof
    Mansouri, Kambiz
    Bauknecht, Thomas
    Hahn, Meinhard
    [J]. CLINICAL BREAST CANCER, 2007, 7 (07) : 555 - 558
  • [4] Doxorubicin and cyclophosphamide followed by weekly docetaxel (AC-T) as neoadjuvant chemotherapy in operable breast cancer patients:: GEICAM 2002-03 Study
    Estévez, LG
    Adrover, E
    Barnadas, A
    Cuevas, JM
    Seguí, MA
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S229 - S229
  • [5] A phase II study of docetaxel followed by vinorelbine and doxorubicin in the neoadjuvant treatment of locally advanced breast cancer
    Youssef, A. C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: results from a phase II study
    Silvia Antolín
    Ramón Mel
    Manuel Ramos
    Andrés García-Palomo
    Concepción Almanza
    Laura de Paz
    Lourdes Calvo
    Elena Álvarez
    Ana González
    Jesús García-Mata
    [J]. Clinical and Translational Oncology, 2011, 13 : 686 - 691
  • [7] A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: results from a phase II study
    Antolin, Silvia
    Mel, Ramon
    Ramos, Manuel
    Garcia-Palomo, Andres
    Almanza, Concepcion
    de Paz, Laura
    Calvo, Lourdes
    Alvarez, Elena
    Gonzalez, Ana
    Garcia-Mata, Jesus
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (09): : 686 - 691
  • [8] Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer
    Tuxen, Malgorzata K.
    Cold, Soeren
    Tange, Ulla B.
    Balslev, Eva
    Nielsen, Dorte L.
    [J]. ACTA ONCOLOGICA, 2014, 53 (10) : 1440 - 1445
  • [9] Weekly docetaxel as neoadjuvant treatment in stage II and III breast cancer.: Final results of a phase II, multicenter GEICAM study
    Gacia-Estévez, L
    Cuevas, J
    Antón, A
    Florián, J
    López-Vega, J
    Velasco, A
    Lobo, F
    Fortes, J
    Díaz, FJ
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 : S65 - S65
  • [10] Phase II study of neoadjuvant docetaxel/vinorelbine followed by surgery and adjuvant doxorubicin/cyclophosphamide in women with stage II/III breast cancer
    Limentani, Steven A.
    Brufsky, Adam M.
    Erban, John K.
    Jahanzeb, Mohammed
    Lewis, Deborah
    [J]. CLINICAL BREAST CANCER, 2006, 6 (06) : 511 - 517
12345